Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay

Journal of Biotechnology

Volumn 164, Issue 1, 2013, Pages 137-142

  Heintz Buschart, Anna ^a   Eickhoff, Holger ^b   Hohn, Erwin ^b   Bilitewski, Ursula ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b EMC MICROCOLLECTIONS GMBH   (Germany)

Author keywords

Beta galactosidase; HWP1; Morphology; Reporter strain

Indexed keywords

BETA-GALACTOSIDASE; CANDIDA ALBICANS; HIGH-THROUGHPUT SCREENING; HWP1; NITROGEN STARVATION; PROMOTER ACTIVITIES; SCREENING ASSAYS; SYNTHETIC COMPOUNDS;

CANDIDA; CARBOXYLATION; DIAGNOSIS; MORPHOLOGY; PATHOGENS;

YEAST;

ANTIFUNGAL AGENT; BETA GALACTOSIDASE; DIHYDROBENZO[D]ISOXAZOLONE; METHYL ARYL OXAZOLINE CARBOXYLATE; THIAZOLO[4,5 EPSILON]BENZOISOXAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CHEMICAL STRUCTURE; CYTOTOXICITY; ENZYME ACTIVITY; FUNGAL DEVELOPMENT; FUNGAL STRAIN; FUNGUS CULTURE; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER SCREENING ASSAY; YEAST TO HYPHAE;

ANTIFUNGAL AGENTS; BETA-GALACTOSIDASE; CANDIDA ALBICANS; CELL LINE, TUMOR; CELL SURVIVAL; FUNGAL PROTEINS; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYPHAE; MEMBRANE GLYCOPROTEINS; MICROBIAL SENSITIVITY TESTS; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS;

CANDIDA ALBICANS; FUNGI;

EID: 84875106234     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.12.004     Document Type: Article

References (51)

1. Akerey B., Le-Lay C., Fliss I., Subirade M., Rouabhia M. In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells. Journal of Applied Microbiology 2009, 107:1298-1307.
2. Arai T., Mikami Y., Yokoyama K. Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils. Sabouraudia 1977, 15:171-177.
3. Biswas K., Morschhäuser J. The Mep2p ammonium permease controls nitrogen starvation-induced filamentous growth in Candida albicans. Molecular Microbiology 2005, 56:649-669.
4. Bockmühl D.P., Krishnamurthy S., Gerads M., Sonneborn A., Ernst J.F. Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans. Molecular Microbiology 2001, 42:1243-1257.
5. Burger-Kentischer A., Finkelmeier D., Keller P., Bauer J., Eickhoff H., Kleymann G., Abu Rayyan W., Singh A., Schröppel K., Lemuth K., Wiesmüller K.H., Rupp S. A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives. Antimicrobial Agents and Chemotherapy 2011, 55:4789-4801.
6. Calderone R.A., Fonzi W.A. Virulence factors of Candida albicans. Trends in Microbiology 2001, 9:327-335.
7. Calugi C., Trabocchi A., Guarna A. Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002-2010). Expert Opinion on Therapeutic Patents 2011, 21:381-397.
8. Chen X., Wu R. Direct amplification of unknown genes and fragments by Uneven polymerase chain reaction. Gene 1996, 185:195-199.
9. Csank C., Schröppel K., Leberer E., Harcus D., Mohamed O., Meloche S., Thomas D.Y., Whiteway M. Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infection and Immunity 1998, 66:2713-2721.
10. Fang H.M., Wang Y. RA domain-mediated interaction of Cdc35 with Ras1 is essential for increasing cellular cAMP level for Candida albicans hyphal development. Molecular Microbiology 2006, 61:484-496.
11. Feng Q., Summers E., Guo B., Fink G. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. Journal of Bacteriology 1999, 181:6339-6346.
12. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. Journal of the National Cancer Institute 1973, 51:1417-1423.
13. Gubbins P.O., Amsden J.R. Drug-drug interactions of antifungal agents and implications for patient care. Expert Opinion on Pharmacotherapy 2005, 6:2231-2243.
14. Hisajima T., Maruyama N., Tanabe Y., Ishibashi H., Yamada T., Makimura K., Nishiyama Y., Funakoshi K., Oshima H., Abe S. Protective effects of farnesol against oral candidiasis in mice. Microbiology and Immunology 2008, 52:327-333.
15. Hogan D.A., Vik A., Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Molecular Microbiology 2004, 54:1212-1223.
16. Hornby J.M., Jensen E.C., Lisec A.D., Tasto J.J., Jahnke B., Shoemaker R., Dussault P., Nickerson K.W. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Applied and Environment Microbiology 2001, 67:2982-2992.
17. Jarosz L.M., Krom B.P. Rapid screening method for compounds that affect the growth and germination of Candida albicans, using a real-time PCR thermocycler. Applied and Environment Microbiology 2011, 77:8193-8196.
18. Jiang B., Bussey H., Roemer T. Novel strategies in antifungal lead discovery. Current Opinion in Microbiology 2002, 5:466-471.
19. Kippert F. A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells. FEMS Microbiology Letters 1995, 128:201-206.
20. 2 sensing with cAMP signaling and virulence. Current Biology 2005, 15:2021-2026.
21. Köhler J.R., Fink G.R. Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:13223-13228.
22. Lafleur M.D., Lucumi E., Napper A.D., Diamond S.L., Lewis K. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. Journal of Antimicrobial Chemotherapy 2011, 66:820-826.
23. Lane S., Birse C., Zhou S., Matson R., Liu H. DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. Journal of Biological Chemistry 2001, 276:48988-48996.
24. Leberer E., Harcus D., Broadbent I.D., K.L., Dignard D., Ziegelbauer K., Schmidt A., Gow N.A., Brown A.J., Thomas D.Y. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:13217-13222.
25. Li M., Martin S.J., Bruno V.M., Mitchell A.P., Davis D.A. Candida albicans Rim13p, a protease required for Rim101p processing at acidic and alkaline pHs. Eukaryotic Cell 2004, 3:741-751.
26. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. International Journal of Cancer 1976, 17:62-70.
27. Liu H., Köhler J., Fink G.R. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994, 266:1723-1726.
28. Lo H.J., Köhler J.R., DiDomenico B., Loebenberg D., Cacciapuoti A., Fink G.R. Nonfilamentous C. albicans mutants are avirulent. Cell 1997, 90:939-949.
29. Menzel R. A microtiter plate-based system for the semiautomated growth and assay of bacterial cells for beta-galactosidase activity. Analytical Biochemistry 1989, 181:40-50.
30. Miller J. Experiments in Molecular Genetics 1972, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Mitchell L.H., Soll D.R. Commitment to germ tube or bud formation during release from stationary phase in Candida albicans. Experimental Cell Research 1979, 120:167-179.
32. Murad A.M., d'Enfert C., Gaillardin C., Tournu H., Tekaia F., Talibi D., Marechal D., Marchais V., Cottin J., Brown A.J. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Molecular Microbiology 2001, 42:981-993.
33. Murad A.M., Leng P., Straffon M., Wishart J., Macaskill S., MacCallum D., Schnell N., Talibi D., Marechal D., Tekaia F., d'Enfert C., Gaillardin C., Odds F.C., Brown A.J. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO Journal 2001, 20:4742-4752.
34. Perlroth J., Choi B., Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Medical Mycology 2007, 45:321-346.
35. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 2007, 20:133-163.
36. Rocha C.R., Schröppel K., Harcus D., Marcil A., Dignard D., Taylor B.N., Thomas D.Y., Whiteway M., Leberer E. Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Molecular Biology of the Cell 2001, 12:3631-3643.
37. Sasaki T., Otani T., Yoshida K., Unemi N., Hamada M., Takeuchi T. Discovery of methyl-2-(2'-hydroxyphenyl)-2-oxazoline-4-carboxylate as a secondary metabolite from Actinomadura sp. Journal of Antibiotics 1997, 50:881-883.
38. 2+/calmodulin signaling pathway on morphological development of Candida albicans. Biological and Pharmaceutical Bulletin 2004, 27:1281-1284.
39. Saville S.P., Lazzell A.L., Bryant A.P., Fretzen A., Monreal A., Solberg E.O., Monteagudo C., Lopez-Ribot J.L., Milne G.T. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrobial Agents and Chemotherapy 2006, 50:3312-3316.
40. Schweizer A., Rupp S., Taylor B.N., Röllinghoff M., Schröppel K. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Molecular Microbiology 2000, 38:435-445.
41. Shareck J., Belhumeur P. Modulation of morphogenesis in Candida albicans by various small molecules. Eukaryotic Cell 2011, 10:1004-1012.
42. Staab J.F., Bradway S.D., Fidel P.L., Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999, 283:1535-1538.
43. Staab J.F., Ferrer C.A., Sundstrom P. Developmental expression of a tandemly repeated, proline- and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. Journal of Biological Chemistry 1996, 271:6298-6305.
44. Stoldt V.R., Sonneborn A., Leuker C.E., Ernst J.F. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO Journal 1997, 16:1982-1991.
45. Tortorano A.M., Peman J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., Biraghi E., Canton E., Zimmermann K., Seaton S., Grillot R. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. European Journal of Clinical Microbiology and Infectious Diseases 2004, 23:317-322. ECMM Working Group on Candidaemia.
46. Uhl M.A., Johnson A.D. Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology 2001, 147:1189-1195.
47. Vermes A., Guchelaar H.J., Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. Journal of Antimicrobial Chemotherapy 2000, 46:171-179.
48. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 2004, 39:309-317.
49. Xu W., Mitchell A.P. Yeast PalA/AIP1/Alix homolog Rim20p associates with a PEST-like region and is required for its proteolytic cleavage. Journal of Bacteriology 2001, 183:6917-6923.
50. Zhang J., Chung T., Oldenburg K. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening 1999, 4:67-73.
51. Zou H., Fang H.M., Zhu Y., Wang Y. Candida albicans Cyr1, Cap1 and G-actin form a sensor/effector apparatus for activating cAMP synthesis in hyphal growth. Molecular Microbiology 2010, 75:579-591.